Sun playing with GMP-violation fire; label changes drive flu vax delay;

> India-based Sun has again been slapped by the FDA for trouble in its U.S. business. Article

> Expect some flu vaccine delays now that three manufacturers are making label changes, warning U.S. healthcare providers that the syringe tip caps may contain natural rubber latex. Announcement

> A nuclear magnetic resonance technique underlies what Swedish researchers hope will become a small briefcase, into which pharmacists and customs officers can place a packet of tablets and a minute later find out whether the drug is authentic. Release

> Ombudsman programs and hotlines into neutral corporate territory, where individuals can confidentially report concerns, are ways to preserve the necessary independence of the QA group. Blog

> Bend Research has received a U.S. patent for its process that uses pressure nozzles to make spray-dried solid amorphous large-particle drug dispersions. Bend release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.